Abstract
Noninvasive assessment of endothelial dysfunction (ED) and diagnosing the early vascular development of atherosclerosis in active mucocutaneous Behçet’s disease. Twenty-nine active BD patients (study group) without any obstructive vascular involvement were compared with twenty-nine healthy controls (control group) in terms of ED utilizing endothelium-dependent dilation as well as endothelium-independent dilation (FMD), which was assessed by measuring changes in brachial artery diameter following sublingual glyceril trinitrate (400 μg Nitrolingual spray). All patients underwent a complete transthoracic echocardiographic and tissue Doppler study. A standard form was utilized for the documentation of the presence or absence of the known risk factors for atherosclerotic vascular disease. Statistical analysis was performed by utilizing SPSS version 11. There was no difference between patients and controls in terms of echocardiographic and tissue Doppler parameters as well as baseline brachial artery diameters. Flow-mediated dilation showed 38% impairment in study group compared with control (P < 0.05). Endothelium-independent NTG dilatation did not differ in both groups. Ultrasonography is an easily applicable noninvasive method for following BD patients for the risk of ED, which may preclude to atherosclerosis, save time and cost-effective.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
International Study Group for Behçet’s disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
Koc Y, Gullu I, Akpek G, Akpolat T, Kansu E, Kiraz S, Batman F, Kansu T, Balkanci F, Akkaya S et al (1997) Vascular involvement in Behçet’s disease. J Rheumatol 19:402–410
Ehrlich GE (1997) Vasculitis in Behçet’s disease. Int Rev Immunol 14:81–88
Espinosa G, Font J, Tassies D, Vidaller A, Deulofeu R, Lopez-Soto A, Cervera R, Ordinas A, Ingelmo M, Reverter JC (2002) Vascular involvement in Behçet’s disease relation with thrombophilic factors, coagulation activation, and thrombomodulin. Am J Med 112:37–43
Kiraz S, Ertenli I, Ozturk MA, Haznedaroglu IC, Celik I, Calguneri M (2002) Pathological haemostasis and ‘prothrombotic state’ in Behçet’s disease. Thromb Res 105:125–133
Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111–1115
Henry WL, De Maria A, Gramiak R, King DL, Kisslo JA, Popp RL, Sahn DJ, Schiller NB, Tajik A, Teicholz LE, Weyman AE (1980) Report of the American Society of Echocardiography Committee on nomenclature and standards in two-dimensional echocardiography. Circulation 62:212–217
Quiňones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA (2002) Recommendations for quantification of Doppler echocardiography: a report from the Doppler quantification task force of the nomenclature and standarts committee of the American Society of Echocardiography. J Am Soc Echocardiogr 15:167–184
Agricola E, Galderisi M, Oppizzi M, Schinkel AFL, Maisano F, De Bonis M, Margonato A, Maseri A, Alfieri O (2004) Pulsed tissue Doppler imaging detects early myocardial dysfunction in asymptomatic patients with severe mitral regurgitation. Heart 90:406–410
Ormerod AD, Weller R, Copeland P, Benjamin N, Ralston SH, Grabowski P, Herriot R (1998) Detection of nitric oxide and nitric oxide synthases in psoriasis. Arch Dermatol Res 290:3–8
Cals-Grierson MM, Ormerod AD (2004) Nitric oxide function in the skin. Nitric Oxide 10:179–193
Kellogg DL Jr, Crandall CG, Liu Y, Charkoudian N, Johnson JM (1998) Nitric oxide and cutaneous active vasodilation during heat stress in humans. J Appl Physiol 85:824–829
Minson CT, Berry LT, Joyner MJ (2001) Nitric oxide and neurally mediated regulation of skin blood flow during local heating. J Appl Physiol 91:1619–1626
Kose K, Yazici C, Cambay N et al (2002) Lipid peroxidation and erythrocyte antioxidant enzymes in patients with Behçet’s disease. Tohoku J Exp Med 197:9–16
Oflaz H, Mercanoglu F, Karaman O, Kamali S, Erer B, Genchallac H, Pamukcu B, Umman S, Inanc M, Gul A (2005) Impaired endothelium-dependent flow-mediated dilation in Behçet’s disease: more prominent endothelial dysfunction in patients with vascular involvement. Int J Clin Pract 59:777–781
Sandikci R, Turkmen S, Guvenen G et al (2003) Lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet’s disease. Acta Derm Venerol (Stockh) 83:342–346
Orem A, Yandi YE, Vanizor B et al (2002) The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet’s disease. Clin Biochem 53:217–224
Chambers JC, Haskard DO, Kooner JS (2001) Vascular endothelial function and oxidative stress mechanism in patients with Behçet’s syndrome. J Am Coll Cardiol 37:517–520
Filer AD, Gardner-Medwin JM, Thambyrajah J et al (2003) Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa. Ann Rheum Dis 62:162–167
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ulusoy, R.E., Karabudak, O., Kilicaslan, F. et al. Noninvasive assessment of impaired endothelial dysfunction in mucocutaneous Behçet’s disease. Rheumatol Int 28, 617–621 (2008). https://doi.org/10.1007/s00296-007-0491-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-007-0491-6